https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Communique-de-presse-Sanofi-poursuit-sa-trajectoire-de-leadership-en-immunologie-avec-Dupixent--39891471/?utm_source=telegram&utm_medium=social&utm_campaign=share